CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammationKathryn E. Beckermann, Jeffrey C. Rathmell, Caroline E. Roe et al.|JCI Insight|2020Cited by 95
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C. Contreras, Jeffrey C. Rathmell, Jacqueline Cephus et al.|The Journal of Immunology|2021Cited by 35
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Kathryn E. Beckermann, Anupama Reddy et al.|Cancers|2021Cited by 16
Targeting metabolic dysregulation of T cells in kidney cancer.Katy Beckermann, Jeffrey C. Rathmell, Kirsten Young et al.|Journal of Clinical Oncology|2020Cited by 14